Abstract
In addition to metabolic and cardiovascular disorders, obesity is associated with adverse cognitive and emotional outcomes. Its growing prevalence during adolescence is particularly alarming since recent evidence indicates that obesity can affect hippocampal function during this developmental period. Adolescence is a decisive period for maturation of the amygdala and the hypothalamic–pituitary–adrenal (HPA) stress axis, both required for lifelong cognitive and emotional processing. However, little data are available on the impact of obesity during adolescence on amygdala function. Herein, we therefore evaluate in rats whether juvenile high-fat diet (HFD)-induced obesity alters amygdala-dependent emotional memory and whether it depends on HPA axis deregulation. Exposure to HFD from weaning to adulthood, i.e., covering adolescence, enhances long-term emotional memories as assessed by odor–malaise and tone–shock associations. Juvenile HFD also enhances emotion-induced neuronal activation of the basolateral complex of the amygdala (BLA), which correlates with protracted plasma corticosterone release. HFD exposure restricted to adulthood does not modify all these parameters, indicating adolescence is a vulnerable period to the effects of HFD-induced obesity. Finally, exaggerated emotional memory and BLA synaptic plasticity after juvenile HFD are alleviated by a glucocorticoid receptor antagonist. Altogether, our results demonstrate that juvenile HFD alters HPA axis reactivity leading to an enhancement of amygdala-dependent synaptic and memory processes. Adolescence represents a period of increased susceptibility to the effects of diet-induced obesity on amygdala function.
Introduction
Obesity, primarily attributable to overconsumption of energy-dense food, is considered one of the most serious public health challenges. Indeed, it is associated with cardiovascular diseases, metabolic disorders, and cancers, causing disability and premature death (Malnick and Knobler, 2006; World Health Organization, http://www.who.int/mediacentre/factsheets/fs311/en/). Obesity also affects brain function and induces cognitive disturbances, including impairments of declarative memory, attention, or executive functioning (Nilsson and Nilsson, 2009; Sellbom and Gunstad, 2012; Francis and Stevenson, 2013). Obesity has also been associated with adverse emotional outcomes, especially with increased anxiety and depression (Hawkins and Stewart, 2012, Dixon et al., 2013), as well as with a higher prevalence of emotional disorders such as post-traumatic stress disorder (PTSD; Pagoto et al., 2012; Johannessen and Berntsen, 2013), which is linked to enduring and maladaptive emotional memory (Elzinga and Bremner, 2002; Layton and Krikorian, 2002). However, a thorough examination of the effects of obesity on emotional memory is still lacking.
Albeit most of the studies on the effect of high-fat diet (HFD) on cognitive and emotional functions focused on adult individuals, overweight and obese adolescents also exhibit cognitive and emotional alterations (Cserjési et al., 2007, Li et al., 2008). The prevalence of obesity in adolescents is still increasing at an alarming rate (Ogden et al., 2012). This is particularly worrisome since adolescence is a period of neurobehavioral shaping required for lifelong cognitive processing (Spear, 2000) that is particularly sensitive to environmental challenges, like excessive food intake (Andersen, 2003; Vendruscolo et al., 2010). We recently demonstrated in animal models that juvenile obesity induced by HFD consumption impaired hippocampal function, in particular spatial and relational memories (Boitard et al., 2012, 2014). However, the same HFD exposure restricted to adulthood did not induce such effects (Boitard et al., 2012, 2014), suggesting that adolescence represents a vulnerable period for the effect of HFD on memory. Here, we hypothesized that, similarly to hippocampal-dependent memory, emotional memory could be highly vulnerable to juvenile HFD exposure.
Emotional control of behavior critically depends on amygdala (Fanselow and Gale, 2003; LeDoux, 2003; Maren, 2005). In particular, the basolateral amygdala (BLA) modulates long-term aversive memory (McGaugh, 2004) under the influence of glucocorticoid hormones, the final product of the hypothalamic–pituitary–adrenal (HPA) axis (Roozendaal et al., 2009; Finsterwald and Alberini, 2014). The amygdala and the HPA axis show parallel maturational processes during late childhood and adolescence (Spear, 2000; McCormick and Mathews, 2010; Foilb et al., 2011). Importantly, obesity is associated with HPA axis deregulation in humans (Pasquali et al., 2006), and chronic HFD-induced obesity in animals alters HPA axis function (Legendre and Harris, 2006; Sharma and Fulton, 2013; Tannenbaum et al., 1997). Therefore, the emotional disturbances observed in obese adults could result from diet-induced perturbations during late development of the neural circuits controlling emotional behaviors. The present study directly addresses this issue. We show that HFD-induced obesity during adolescence has a major neurocognitive effect on emotional behaviors. Moreover, our data reveal a causal link between changes in the modulation of amygdala plasticity by glucocorticoids and HFD-induced increase in emotional memory.
Materials and Methods
Procedures were performed in accordance with French (Directive 87/148, Ministère de l'Agriculture et de la Pêche) and international (Directive 86/609; November 24, 1986; European Community) legislation and were approved by the local ethical committee (agreement number 5012047-A).
Animals and diets
Wistar naive male rats (Janvier), aged either 3 weeks (juvenile group) or 12 weeks (adult group) when they arrived, were housed in groups of two to four individuals in polycarbonate cages (48 × 26 × 21 cm) in a climatized (22 ± 1°C) room maintained under a 12 h light/dark cycle (lights on at 8:00 A.M., lights off at 8:00 P.M.). They had ad libitum access to food and water from their arrival until they were killed. Food provided since their arrival was either a control diet (CD) offering 2.9 kcal/g (consisting of 2.5% lipids and 60% carbohydrate, mostly from starch; A04, SAFE) or a high-fat diet offering 4.7 kcal/g [consisting of 24% lipids (45 kcal), mostly saturated fat from lard, and 41% carbohydrates (35 kcal); D12451, Research Diets]. One week before behavioral experiments, rats were housed individually (cage, 35 × 23 × 19 cm) and handled by the experimenter. All rats were exposed to CD or HFD for 4 months starting either at weaning (3 weeks old; jCD and jHFD groups), i.e., exposure throughout adolescent development (from weaning to adulthood; Spear, 2000), or at adulthood (12 weeks old; aCD and aHFD groups), i.e., with the clear exclusion of adolescence (Fig. 1A). All behavioral experiments were performed after 3 months of HFD exposure, and rats were killed after 4 months of diet exposure. One group was exposed to either CD or HFD, starting at weaning, for only 1.5 months before the behavioral experiment. Animals were weighed once per week from their arrival until they were killed. The metabolic status of the animals was evaluated by measuring plasma cholesterol, triglycerides, insulin, and leptin using specific kits (cholesterol RTU and triglycerides enzymatique PAP 150; Biomérieux) or milliplex (rat serum adipokine kit; Millipore). The blood glucose level was assessed after a 24 h food deprivation by tail nick using Accu-Check devices (sensitivity, 10 mg/dl; Roche Diagnostics).
Effects of juvenile and adult HFD intake on conditioned odor aversion, auditory fear conditioning, and anxiety-like behavior
Conditioned odor aversion.
Conditioned odor aversion (COA) results from the association of an odorized tasteless solution [conditioned stimulus (CS)] with a visceral malaise [unconditioned stimulus (US)]. Rats were acclimated to a water-deprivation regimen for 4 d. Access to water was provided in a graded bottle (with 0.5 ml accuracy) placed in the rats' home cage for 15 min each day between 9:00 and 11:00 A.M. Baseline water consumption was obtained by averaging the intake of the last 3 days. On day 5, rats had access for 15 min to almond- or banana-scented water composed of 0.01% benzaldehyde or isopentyl acetate, respectively, diluted in tap water (Sigma; Sevelinges et al., 2009). After a delay of 30 min, rats received an intraperitoneal injection of the visceral malaise-inducing drug lithium chloride (LiCl; Sigma; 25 mg/kg, 0.075 m, 0.75% of body weight) or saline (NaCl, 0.15 m, 0.75% of body weight). On days 6 and 7, rats had access to water for 15 min each day to re-establish baseline water intake. Finally, on day 8, long-term memory of the odor aversion was assessed by providing access to the almond-scented water for 15 min, immediately followed by 15 min of water. In some experiments, rats underwent 2 other days of testing similar to the first one to verify that animals extinguished the aversion. The percentage of scented water consumption with respect to water baseline was used as a measure of neophobia during acquisition and aversion strength during the test.
In another experiment, short-term memory of COA was assessed 4 h after odor–malaise association, as described previously (Desgranges et al., 2008). The procedure was identical to the one described above for COA with the exception that rats were trained to take a water ration twice per day in their home cages: each morning, they had access to 10 ml of tap water during a 15 min period, and then 4.5 h later they had ad libitum access to water for 15 min. On day 5, rats had a restricted access to 10 ml (instead of ad libitum access) of almond-scented solution for 15 min. After a delay of 30 min, rats received LiCl injection, and 4 h later they were confronted again with almond-scented water, followed by tap water. This procedure allows enhancing liquid consumption during the short-term memory test (Ferreira et al., 2002; Desgranges et al., 2008).
Auditory fear conditioning.
This procedure is based on the pairings of an auditory tone (CS) with electric footshocks (US). Fear conditioning was realized in cages (40 × 30 × 35 cm; Imetronics) located in sound-proof chambers with 55 dB constant noise and diodes promoting constant light. Tones (5000 Hz, 70 dB) lasted 10 s, and electric footshocks (0.3 mA, 6 Hz, 1 s) were delivered during the last second of the tone, from a constant-current generator to the stainless steel grid of the floor of each chamber. On day 1, rats were placed in “context A” cages for 8 min during which they received five CS–US pairings (intervals were 120, 60, 80, 40, 100, and 80 s). On day 2, rats were re-exposed to the context A for 10 min without any tone or footshock, allowing testing for contextual fear conditioning. Rats were then placed in “context B” for 25 min (made triangular by the addition of an opaque plastic slab in the diagonal of the chamber with modified patterns on the walls and a rough plastic slab covering the grid floor) and re-exposed to the 10 s tone without footshocks every 5 min after an initial 5 min tone-free period. Rats' behavior during all sessions was recorded through a camera connected to a monitor allowing automatic analysis of freezing response (Marchand et al., 2003), i.e., total immobility except for movements related to breathing (Blanchard and Blanchard, 1969).
Anxiety-like behavior and locomotor activity.
One to 2 weeks before fear conditioning, rats were tested in the open-field task and in the elevated plus maze between 9:00 and 11:00 A.M. The open-field apparatus was made of a white wooden box (100 × 100 × 50 cm) without bedding litter and placed in a brightly lit room (60 lux in its center), which constitutes an anxiogenic setup. Each experimental rat was placed facing the wall in a corner of the open field and allowed free exploration for 10 min. A camera wired to an automated tracking system (SMART version 2.5.20; Panlab) was used to track the rat's locomotion in the open field. Using the software, the open field was divided in a central and peripheral zone in which total distance covered and time spent were analyzed. The elevated plus maze was assessed 5 d after the open-field test. The elevated plus maze apparatus was a black plastic maze made of four arms (12 × 50 cm); two of the arms were closed with walls (45 cm high) providing shelter. Open arms were anxiogenic since the maze was placed 60 cm above the floor in a bright light room (60 lux in its center). Rats were placed in the center facing an open arm and allowed free exploration for 5 min. Time spent in each arm and the number of entries in each arm were recorded. A percentage of open-arm entries with respect to the total number of entrances (open plus closed arms) was calculated.
Effects of juvenile and adult HFD intake on amygdala neuronal activation
Since LiCl injection induces neuronal activation in the amygdala (Yamamoto et al., 1997; Koh et al., 2003; Ferreira et al., 2006), we measured c-fos and Egr-1 expressions in the central amygdale (CeA) and BLA nuclei. Rats were given injections of a lethal dose of pentobarbital sodium (1 ml, i.p.) 90 min after an intraperitoneal injection of saline or LiCl (0.075 m; Sigma; 0.75% of body weight, 25 mg/kg). They were then perfused with 0.1 m PBS (pH 7.4), followed by 4% paraformaldehyde (PFA) in PBS. Brains were quickly removed and stored at 4°C in a 4% PFA for 24 h to allow postfixation. The next day, they were submerged in a 30% sucrose solution at 4°C for 48 h to allow cryoprotection. Finally, brains were frozen in isopentane and stored at −80°C. Coronal sections of 40 μm were incubated in PBS containing 3% bovine serum albumin (BSA) and 0.5% Triton (PBS-BSA-T) to block nonspecific binding sites and to facilitate antibody penetration. The sections were also saturated with 0.3% hydrogen peroxide for 30 min to eliminate endogenous peroxydase activity. Sections were first incubated with the primary anti-c-Fos antibody (anti-c-Fos rabbit polyclonal antibody, 1:1000 diluted in PBS-BSA-T; Santa Cruz Biotechnology) or anti-Egr-1 antibody (anti-Zif rabbit monoclonal antibody, 1:1000 diluted in PBS-BSA-T; Cell Signaling) for 24 h at 4°C. Sections were then incubated for 2 h with the biotinylated secondary antibody (goat anti-rabbit IgG, diluted 1:2000 in PBS for both c-Fos and Egr-1 immunostaining; Vector Laboratories) at room temperature, followed by 1 h incubation in the avidin–biotin–peroxydase complex solution (ABC solution, Vectastain, diluted 1:1000 in PBS; Vector Laboratories). Between each treatment, sections were thoroughly rinsed with PBS. The peroxydase complex was visualized after incubation for 10 min in a mix containing diaminobenzidine, ammonium chloride, ammonium sulfate, sodium acetate, glucose, and glucose oxydase. Sections were incubated in sodium acetate (twice for 10 min) to stop the enzymatic reaction, rinsed in PBS, mounted on gelatin-coated slides, dehydrated, and coverslipped. Labeling was quantified bilaterally on four sections spaced 240 μm apart and chosen to cover the whole amygdala [2.5–3.4 mm posterior to bregma, according to Paxinos and Watson (1998)]. Each section was photographed using Nikon-ACT-1 software, and labeled cells were counted with ImageJ software on a surface representing 0.85 mm2. Results were expressed for 1 mm2. The number of cells expressing glucocorticoid receptors (GRs) was also measured using a similar immunohistochemical procedure, except that a mouse monoclonal anti-GR antibody (1:500; Abcam) and a biotinylated horse anti-mouse antibody (1:1000; Vector Laboratories) were used.
Effects of juvenile and adult HFD intake on corticosterone release
Corticosterone release after gastric malaise or restraint stress.
In juvenile and adult exposed rats used to assess amygdala activation, blood was collected transcardially 90 min after LiCl or saline injection, i.e., after pentobarbital injection and before cardiac perfusion. In different cohorts of juvenile exposed rats previously used for COA experiments, blood was quickly collected from a tail nick just before and 30, 90, and 180 min after intraperitoneal injection of LiCl (25 mg/kg) or restraint stress (in a plastic ventilated tube allowing no movement, for 30 min). The area under the curve (AUC) was calculated to search for a global effect.
Basal corticosterone level.
Blood was quickly collected from a tail nick of juvenile exposed rats every 2–4 h from 7:00 A.M. to 11:00 P.M. to evaluate the impact of jHFD on HPA circadian activity. In other rats, blood from a tail nick was collected either at the beginning of the inactive (light) phase (∼9:00 A.M., lights on at 8:00 A.M.), corresponding to low corticosterone levels, or at the beginning of the active (dark) phase (∼8:00 P.M., lights off at 8:00 P.M.), corresponding to the peak of corticosterone levels.
Corticosterone level measurement.
The total corticosterone level was measured, in plasma obtained after centrifugation of the blood samples (10,000 rpm, 10 min, 4°C), by an in-house radioimmunoassay (described by Richard et al., 2010). Briefly, after absolute ethanol steroid extraction from plasma samples, total corticosterone was measured by competition between cold corticosterone and radioactive corticosterone for a specific anti-corticosterone antibody provided by Dr. H. Vaudry (University of Rouen, Rouen, France). Sensitivity of the technique was 0.3 μg/dl with 10% variability intra- and inter-assay.
Adrenal glands.
The adrenal glands of juvenile exposed rats previously used for fear conditioning were collected (two per animal) and weighed.
Effects of BLA infusion of a GR antagonist on conditioned odor aversion after juvenile and adult HFD intake
Rats underwent surgery after 2.5 months of diet exposure [starting either at weaning (n = 47) or at adulthood (n = 39)] to implant cannulae just above the BLA to allow later infusion of a specific GR antagonist, mifepristone (RU486; Sigma), into the BLA. For this purpose, rats were anesthetized (70 mg/kg ketamine and 6 ml/kg xylazine, i.p.) and placed in a stereotaxic frame. Two guide cannulae (7 mm under pedestal, 23 gauge) were implanted bilaterally 2.0 mm above the BLA (2.8 mm posterior to bregma, 5.1 mm lateral; 5.5 mm below skull surface; Paxinos and Watson, 1998) and fixed to the skull by dental acrylic cement and surgical screws. Stylets were inserted in the guide cannulae to prevent obstruction. At the end of the surgery, rats were awakened by Antisedan injection (0.2 ml per rat) and allowed at least 1 week to recover before starting the water-deprivation regimen. Rats were then habituated to be gently held for infusion. The COA procedure was identical to the one described above with the exception that, on the acquisition day, 30 min after receiving odorized water, animals received intra-BLA infusion of either saline or RU486 immediately before the intraperitoneal LiCl injection. After stylets were removed, infusion needles (30 gauge) were inserted in the guide cannulae, with tips protruding 2 mm below, i.e., reaching the BLA. Injection needles were connected to Hamilton microsyringes placed in an automated microinfusion pump allowing bilateral delivery (0.25 μl each side, rate of 0.25 μl/min) of RU486 (diluted in 2% ethanol in saline to reach a final concentration of 3 ng in 0.25 μl) or vehicle (2% ethanol in 0.25 μl of saline). Dose of drug and volume were chosen according to previous findings (Roozendaal and McGaugh, 1997; Donley et al., 2005). Needles remained in the guide cannulae for an additional 1 min after infusion to minimize liquid dragging, and stylets were reinserted into the guide cannulae. After the experiments, rats were killed, and brains were removed. Coronal sections (40 μm) were collected around guide cannulae and stained with cresyl violet to determine cannulae placement. Nine rats with unilateral or bilateral cannulae misplacement were discarded from statistical analysis.
Effects of a GR antagonist on amygdala synaptic plasticity after juvenile HFD intake
The synaptic plasticity of the BLA was explored in vivo in anesthetized animals using long-term potentiation (LTP) induced in the BLA by high-frequency stimulation of the entorhinal cortex. This pathway was chosen because it clearly modulates BLA synaptic plasticity (Yaniv et al., 2003; Vouimba et al., 2004; Mouly and Di Scala, 2006) and participates in COA memory formation (Ferry et al., 1999).
Rats were anesthetized with Equithesin (2.12% w/v MgSO4, 10% v/v ethanol, 39.1% v/v propylene glycol, 0.98% w/v sodium pentobarbital, and 4.2% w/v chloral hydrate; 0.3/0.5 ml/kg) and placed in a stereotaxic frame, with body temperature maintained at 37 ± 0.5°C. Briefly, small holes were drilled into the skull to allow the insertion of electrodes into the brain. A recording microelectrode (glass; tip diameter, 2.5 μm; filled with 2 m NaCl; resistance, 1.4 MΩ) was slowly lowered into the BLA (3.1 mm posterior to bregma; 5.0 mm lateral; 7/7.6 mm below skull surface). A bipolar 125 μm stimulating electrode was implanted in the entorhinal cortex (6.5 mm posterior to bregma; 5.5 mm lateral; 5.0/5.8 mm below skull surface). The evoked responses were digitized (10 kHz) and analyzed using the 1401+ (Cambridge Electronic Design) and its Spike2 software. Off-line measurements were made on the amplitude of field postsynaptic potentials using averages of five successive responses to a given stimulation intensity applied at 0.1Hz. Test stimuli (monopolar pulses; 100 μs duration) were delivered at 0.1 Hz. After positioning the electrodes, the rats were left for 30 min before beginning the experiment. LTP was induced in the BLA by theta-like high-frequency stimulation at 100 Hz (TS-100) to the entorhinal cortex (three sets of 10 trains, each train consisted of 10 pulses at 100 Hz, intertrain interval of 200 ms, interset interval of 1 min). For all the experiments, baseline responses were established by means of delivering stimulation intensity (50–150 μA) sufficient to elicit a response representing ∼25/30% of the maximal amplitude of the evoked field potentials. Animals received an intraperitoneal injection (1% of body weight) of RU486 (50 mg/kg, diluted in ethanol and saline) or vehicle (ethanol and saline) 30 min before high-frequency stimulation. After the experiments, rats were killed and brains were collected to determine the electrode placement.
Statistical analysis
Data were expressed as the mean ± SEM, and statistical analyses were conducted using Statview software with a threshold for considering statistically significant difference being set up at p ≤ 0.05. The results were analyzed using Student's t tests or two- or three-way ANOVAs with diet (CD vs HFD), exposure duration (1.5 vs 3 months), age (juvenile vs adult), injection (NaCl vs LiCl), and/or drug treatment (RU486 vs vehicle) as between-subject factors and with repeated measurement on the time factor when appropriate. The interactions were further investigated using post hoc Fisher's PLSD tests.
Results
Juvenile and adult HFD intake induces similar morphometric and metabolic changes
Animals exposed to HFD as juveniles or adults were significantly heavier than their respective controls at the time of behavioral assessment (Table 1), and they had significantly higher circulating levels of leptin (jCD, 8 ± 1 ng/ml; JHFD, 16 ± 2 ng/ml; aCD, 9 ± 1 ng/ml; aHFD, 21 ± 5 ng/ml) but not of insulin, glucose, triglycerides, and cholesterol at the time they were killed [for detailed measurements and statistics, see Boitard et al. (2014)].
Juvenile, but not adult, HFD intake enhances aversion memory
We first assessed the effects of 1.5 or 3 months of jHFD on COA, a procedure based on odor–malaise pairing highly dependent on BLA integrity (Desgranges et al., 2008; Sevelinges et al., 2009; Fig. 1A). On the acquisition day, the novel almond-scented water was consumed with similar weak neophobic responses in all groups (∼80% of water baseline; duration × diet effect: F(1,46) = 1.5, p > 0.1; data not shown). Thirty minutes after, the rats received a mild gastric malaise (25 mg/kg LiCl) to induce a moderate aversion. Three days later (long-term memory), all conditioned groups showed reduced consumption of odorized water (compared with water baseline; paired t test: t > 4.6, p < 0.001 for each group; Fig. 1B). A two-way ANOVA conducted on the four conditioned groups indicated a significant exposure duration × diet interaction (F(1,46) = 4.1, p < 0.05). Post hoc analysis revealed that 3 months of exposure to the jHFD group induced a stronger aversion than the other three groups (p < 0.02), which did not differ from one another (p > 0.1; Fig. 1B). During the next 2 d of tests, all groups increased their consumption of the odorized water as confirmed by repeated-measures ANOVAs with a significant effect of time (F(2,92) = 152.1, p < 0.0001) but no interaction between diet, exposure duration, and time (F(2,92) < 1, p > 0.1), indicating a similar extinction rate in all groups (data not shown). We also confirmed that 3 months of jHFD exposure enhanced long-term COA memory using either a different odor CS (banana odor; unpaired t test: jCD, 56 ± 8%; jHFD, 28 ± 9%; t(19) = 2.3, p < 0.05) or a different US, the bacterial lipopolysaccharide (250 μg/kg; jCD, 52 ± 7%; jHFD, 18 ± 3%; t(14) = 2.5, p < 0.05). Altogether, these results indicate that 1.5 months of jHFD exposure did not affect COA, whereas 3 months of exposure enhanced long-term COA memory regardless of what CS or US was used.
We then assessed short-term memory by exposing animals to scented water 4 h after receiving odor–malaise pairing (see Materials and Methods). Both the jCD and jHFD groups showed a similar aversion (jCD, 32 ± 9%; jHFD, 34 ± 11%; unpaired t test, t(11) < 1; data not shown), ruling out the possibility that the stronger aversion seen in the long-term memory test was caused by stronger malaise perception in the jHFD group, and suggest that 3 months of jHFD exposure specifically enhanced memory consolidation.
To evaluate whether the effect was specific to juvenile exposure, adult rats were submitted to HFD for 3 months before COA acquisition (Fig. 1A). Both groups showed a similar aversion 3 d later (aCD, 62 ± 6%; aHFD, 65 ± 12%; unpaired t test, t(22)< 1; data not shown). To confirm these data and directly compare the effects of juvenile and adult exposure to HFD on long-term COA memory, we conducted an experiment with four groups: jCD, jHFD, aCD, and aHFD. During the test, a two-way ANOVA indicated an age × diet interaction (F(1,20) = 4.2, p = 0.05); the jHFD group presented a stronger aversion than the other three groups (p < 0.02), which did not differ from one another (p > 0.1; Fig. 1C). These results indicate that 3 months of HFD exposure at adulthood did not affect COA, stressing the specificity of jHFD effect on COA.
Juvenile, but not adult, HFD intake enhances auditory fear memory
Rats were trained in auditory fear conditioning, which is another memory task critically dependent on BLA (for review, see Fanselow and Gale, 2003; Maren, 2005; LeDoux, 2003). Since the experiments were not conducted at the same time, results from juvenile and adult exposed rats are presented and analyzed separately.
We first conducted an experiment with juvenile exposed rats. On the conditioning day, jHFD and jCD exposed rats showed similar exploratory behavior during the first 2 min before receiving any CS–US pairings (freezing, <10%; no diet effect: t(21) = 1.5, p = 0.15; data not shown). After the first CS–US pairing, freezing increased with time until the end of the conditioning session (F(1,5) = 41.4; p < 0.001 for time effect, no diet or interaction effect; post-shock freezing at the end of the session: 82 ± 4% and 84 ± 6% for jCD and jHFD, respectively). The next day, freezing to the conditioning context was assessed by placing the rats in the same cage without any CS or US. As expected, freezing response was low (15 ± 5% and 13 ± 2% for jCD and jHFD, respectively) and diminished with time, independently of the diet (time effect: F(9,180) = 7.0, p < 0.001, no diet or interaction effect). Freezing to the cue was assessed by exposing rats to the CS in the novel context B. Before being confronted with the first CS, freezing behavior was low and was not affected by the diet (t(21) < 1; Fig. 1D). Once the first CS occurred, freezing increased for both groups, but jHFD rats significantly froze more than the jCD group (t(21) = 2.73, p = 0.012; Fig. 1D), indicating a higher auditory fear memory. Then, freezing decreased during subsequent tone presentations, and at the end of the session there was no effect of diet (jCD, 50 ± 8%; jHFD, 55 ± 8%; t(21) < 1).
Concerning adult exposed rats, both the aCD and aHFD groups showed similar exploratory behavior during the first 2 min before CS–US pairings (freezing, <10%; no diet effect: t(23) < 1; data not shown). After pairing, freezing increased with time until the end of the conditioning session (F(1,5) = 8.65, p < 0.001 for time effect, no diet or interaction effect; postshock freezing at the end of the session: 68 ± 8% and 54 ± 10% for aCD and aHFD, respectively). On the test day, freezing to the conditioning context was minimal and comparable across the aHFD and aCD groups (for the entire session: 15 ± 1% and 20 ± 5% for aCD and aHFD, respectively; t(22) < 1). In the novel context B, freezing behavior was low and was not affected by diet before the first CS (t(23) < 1; Fig. 1E). Once the first CS occurred, freezing increased for both groups, but no diet effect was present (t(23) < 1; Fig. 1E). There were no group differences until the end of the session (aCD, 60 ± 7%; aHFD, 53 ± 8%; t(23) < 1). These data show that juvenile, but not adult, HFD exposure enhances long-term retention of auditory fear conditioning, another amygdala-dependent memory.
To evaluate whether the enhancement of emotional memory after jHFD exposure results from altered locomotor activity or heightened anxiety-like behaviors, we explored the effects of jHFD intake on the open-field test and the elevated plus maze. jHFD consumption did not modify the total distance traveled and the time spent in the center of the open field (t(22) < 1; Fig. 1F), nor the percentage of open-arms entry in the elevated plus maze test (t(22) < 1; Fig. 1G). It therefore appears that jHFD exposure enhances auditory fear memory without affecting locomotor activity or anxiety-like behavior.
Juvenile, but not adult, HFD intake enhances LiCl-induced basolateral amygdala activation
To evaluate whether the higher COA memory in jHFD-fed rats could be related to higher amygdala activation in response to the aversive stimulus, we assessed neuronal activation using c-Fos and Egr-1 immunohistochemistry in the CeA and BLA of both juvenile and adult exposed animals 90 min after LiCl or NaCl injection.
In the CeA, neuronal activation was clearly influenced by LiCl injection but not by diet (Fig. 2A2,B). ANOVA revealed a significant injection effect (c-Fos: F(1,38) = 50.0, p < 0.0001; Egr-1: F(1,38) = 70.9, p < 0.0001) and a significant age × injection interaction (c-Fos: F(1,38) = 4.1, p < 0.05; Egr-1: F(1,38) = 4.7, p < 0.05). These data indicate that LiCl induces strong CeA activation in all groups with a higher activation in juvenile than in adult groups regardless of the diet (Fig. 2A).
In the BLA, neuronal activation after LiCl injection was clearly influenced by the age period of HFD exposure (Fig. 2C–E). ANOVA indicated a significant age × diet interaction (c-Fos: F(1,38) = 12.4, p < 0.001; Egr-1: F(1,38) = 9.0, p < 0.005). This interaction was significant in LiCl-injected groups (c-Fos: F(1,19) = 7.6, p = 0.01; Egr-1: F(1,19) = 5.6, p < 0.03) but only close to significant in NaCl-injected groups (c-Fos and Egr-1: F(1,19) = 3.9, p = 0.06). Post hoc analyses indicated that LiCl injection in the jHFD group induced a significantly higher BLA activation than the other LiCl-injected groups (p < 0.01), which did not differ from one another (p > 0.1; Fig. 2C,D).
Then, we examined whether the stronger BLA activation of jHFD-fed rats could be related to a differential expression of GR in the BLA. However, the number of GR-positive cells in BLA was not different between the jCD and jHFD groups (jCD-NaCl: 30.9 ± 3.7 cells/mm2, jCD-LiCl: 36.6 ± 3.3 cells/mm2, jHFD-NaCl: 37.4 ± 4.3 cells/mm2 and jHFD-LiCl: 35.8 ± 3.6 cells/mm2; no effect of diet, LiCl or interaction: F(1,21) ≤ 3, p ≥ 0.1).
Juvenile, but not adult, HFD intake prolongs LiCl-induced corticosterone release
Given that glucocorticoid hormones clearly modulate amygdala function (Roozendaal et al., 2009), we first compared corticosterone levels 90 min after LiCl or saline injection in both juvenile and adult exposed rats. LiCl induced a higher level of plasma corticosterone in the jHFD group than in the jCD group. This effect did not occur in the aHFD and aCD groups (Fig. 3A). These observations were confirmed by a three-way ANOVA showing a significant diet × age interaction (F(1,40) = 12.1, p < 0.01), a diet × injection interaction (F(1,40) = 4.8, p < 0.05), and an injection × diet × age interaction (F(1,40) = 4.1, p = 0.05). Moreover, the age × diet interaction was found in LiCl-injected groups (F(1,20) = 10.5, p < 0.005) but not in saline-injected groups (F(1,20) = 1.9, p > 1). The diet × injection interaction was found in juvenile (F(1,20) = 4.8, p < 0.05) but not in adult (F < 1, p > 0.1) groups. Post hoc analyses indicated that LiCl injection in the jHFD group induced a significantly higher increase in the corticosterone level than in all the other groups (p < 0.001; Fig. 3A), which did not differ from one another (p > 0.1). These results indicate that HFD intake enhances LiCl-induced corticosterone release specifically after juvenile exposure.
Interestingly, a strong positive correlation appeared between corticosterone levels and the number of c-Fos- or Egr-1 positive cells in the BLA in juvenile groups (n = 24; c-Fos: r = 0.66, Z = 3.7, p = 0.0003, Fig. 3B; Egr-1 r = 0.60, Z = 3.2, p = 0.0014; data not shown) but not in adult groups (n = 24; r < 0.15, Z < 0.6, p > 0.5 for both c-Fos and Egr-1). In juvenile groups, this correlation was present in the LiCl-treated groups (c-Fos: r = 0.73, Z = 2.8, p = 0.006; Egr-1: r = 0.61, Z = 2.1, p = 0.03) but not in the NaCl-injected groups (r < 0.23, Z < 0.7, p > 0.5 for both c-Fos and Egr-1). This suggests that, in jHFD rats, BLA activation after LiCl is directly linked to corticosterone release.
To better characterize the effect of jHFD intake on corticosterone response to LiCl injection, we compared the time course of plasma corticosterone levels in the jHFD and jCD groups (Fig. 3C). Moreover, the levels of circulating corticosterone previously obtained were abnormally high (Fig. 3A), likely because of anesthesia (Vahl et al., 2005). To avoid this effect, blood samples were collected from a tail nick without anesthesia. Repeated-measures ANOVA indicated a close to significant diet × time interaction (F(3,36) = 2.7 p = 0.06). Additional analyses indicated no difference before, at the peak 30 min after injection, or at near basal levels 180 min after LiCl injection (p > 0.1) but showed significantly higher corticosterone levels in the jHFD group 90 min after LiCl injection (p = 0.05; Fig. 3C). The AUC was significantly higher for the jHFD group compared with the jCD group (32,651 ± 5086 vs 18,909 ± 3789; t(12) = 2.2, p = 0.05). These data indicate a protracted corticosterone release in response to LiCl in the jHFD group.
To investigate the generality of this effect, we used restraint stress, another condition known to activate the HPA axis (Vahl et al., 2005). A significant diet × time effect was found (F(3, 39) = 3.4, p < 0.05; Fig. 3D). A strong increase in corticosterone levels was observed in both groups at 30 min, whereas corticosterone levels decreased at 90 min for the jCD group but not for the jHFD group. Higher corticosterone levels in the jHFD group were present at 90 min and, to a lesser extent, at 180 min after restraint stress (p < 0.004 and p < 0.02, respectively, Fig. 3D). The AUC was significantly higher for the jHFD group compared with the jCD group (28,932 ± 1136 vs 19,343 ± 1273; t(13) = 5.3, p < 0.001).
We then examined whether jHFD intake could modify the natural fluctuation of the corticosterone level throughout the day by collecting blood samples every 2–4 h from 7:00 A.M. to 11:00 P.M. There was a highly significant time effect (F(6,90) = 16.2, p < 0.001) confirming circadian rhythm of corticosterone secretion but no diet × time interaction (F < 1) indicating that jHFD did not affect the HPA axis circadian activity (data not shown). Finally, jHFD exposure did not modify the adrenal gland (weight: jHFD rats, 49 ± 1.5 g; jCD rats, 51 ± 3.1 g; t(22) < 1), confirming jHFD consumption did not lead to chronic overactivation of the HPA axis. These results indicate that jHFD exposure induced a protracted stress-induced corticosterone release without altering basal corticosterone levels.
GR activation in basolateral amygdala mediates juvenile HFD-induced enhancement of odor aversion memory
We then assessed whether blocking corticosterone action by specific blockade of GR in the BLA with the antagonist RU486 could attenuate the enhancement of COA memory in jHFD-fed rats without affecting aHFD-fed rats.
In juvenile exposed rats, all animals similarly drank the odorized water during acquisition without any effect of diet (unpaired t test on percentage of water baseline: t(39) < 1; data not shown). BLA infusion of vehicle or RU486 (3 ng) was performed 30 min after odorized water consumption and immediately before gastric malaise induction. During the test, all groups decreased their consumption of odorized water (compared with water baseline: for each group, t > 2.3, p < 0.05), demonstrating a conditioned aversion. The percentage of odorized water intake measured during the test with respect to water baseline consumption is shown in Figure 4B. Importantly, the drug × diet interaction was significant (F(1,37) = 4.7, p = 0.036), which indicates that RU486 dampened the aversion strength depending on the diet. jHFD-veh rats differed from jCD-veh rats (p < 0.001), replicating previous data obtained with unoperated rats. More importantly, the GR antagonist decreased the aversion in jHFD rats (jHFD-veh vs jHFD-RU, p = 0.037; Fig. 4B), whereas it did not affect the odor aversion in jCD rats (p = 0.39, jCD-veh vs jCD-RU). Moreover, the GR antagonist did not totally reverse the aversion of jHFD rats as these rats still differed from jCD-veh and jCD-RU rats (p < 0.01).
In adult exposed rats, all animals similarly drank scented water during acquisition without any effect of diet (percentage of water baseline: t(34) < 1, p = 0.23; data not shown). During the test, all groups similarly decreased their consumption of odorized water (compared with water baseline: for each group, t > 3.1, p < 0.05) without any effect of diet and drug (drug × diet interaction: F(1,32) = 0.11, p = 0.74; Fig. 4C). This indicates that the GR antagonist had no effect on the aversion strength in aHFD-fed rats.
GR activation mediates juvenile HFD-induced enhancement of long-term potentiation in the basolateral amygdala
Synaptic plasticity, specifically LTP, is thought to be the underlying cellular mechanism for learning and memory processes in the brain (Bliss and Collingridge, 1993). We then assessed whether 3 months of HFD consumption since weaning enhanced LTP in BLA and whether blocking GR with RU486 (50 mg/kg) could restore normal levels of BLA plasticity in jHFD-fed rats.
Baseline amplitude before high-frequency stimulation did not differ between groups (F ≤ 1; p > 0.1 for diet, drug, and interaction effects). A two-way repeated-measures ANOVA on the poststimulation recording showed a significant diet × drug interaction on the levels of potentiation in the BLA (F(1,26) = 3.9, p = 0.05; Fig. 4D). Post hoc analysis showed that the jHFD-veh group significantly differed from all the other groups (p < 0.001). One hour after stimulation, the level of potentiation in the jHFD-veh group (129 ± 4%) was still significantly higher than those of the other groups (p < 0.004; 101 ± 6, 97 ± 3, and 105 ± 4% for jCD-veh, jCD-RU486, and jHFD-RU486; Fig. 4E). This level was different from the baseline level only in the jHFD-veh group (t(6) = 4.6, p < 0.01; other groups: t < 1.7, p > 0.1).
Altogether, these results show that jHFD increases LTP in the BLA and that this enhancement is dependent on GR activation.
Discussion
We demonstrate that juvenile consumption of HFD, from weaning to adulthood, enhances long-term aversive memories as assessed by odor–malaise and tone–shock associations. We also found that juvenile HFD exposure prolongs the release of glucocorticoids after aversive stimuli, enhancing BLA activation. These effects are not observed when HFD consumption for a similar duration was confined to adulthood. Interestingly, blockade of GR activation is sufficient to dampen the effects of juvenile HFD intake on increased aversive memory as well as on synaptic plasticity in the BLA.
Our study first shows that juvenile, but not adult, HFD exposure enhances both odor aversion and auditory fear memories. Few studies have investigated the effects of HFD on emotional memory. Our results are consistent with studies showing that genetic mouse models of obesity, for which overweight starts very early after weaning, enhanced flavor aversion memory (Thompson et al., 1993, Ohta et al., 2003), whereas HFD-induced obese mice at adulthood did not affect auditory fear memory (Heyward et al., 2012). However, our results seem contradictory to other studies showing impaired fear memory after early exposure to HFD (Hwang et al., 2010; Yamada-Goto et al., 2012). These studies used more drastic HFD conditions (60% kcal from lipids instead of 45% kcal in our study), which have been shown to influence the effect of HFD on cognitive processes (Pistell et al., 2010). More importantly, the discrepancy seems to be linked to a major procedural difference. In our conditions, fear conditioning leads to high fear response to the cue but not to the context, whereas these studies used delay fear conditioning resulting in predominant contextual fear memory. In contrast to auditory fear conditioning, contextual fear conditioning greatly depends on hippocampal integrity (Rudy et al., 2002; for review, see Maren et al., 2013;), and chronic HFD intake has a clear deleterious effect on hippocampal-dependent plasticity and memory (for review, see Kanoski and Davidson, 2011), in particular after juvenile HFD exposure (Boitard et al., 2012, 2014; Valladolid-Acebes et al., 2013). Interestingly, using trace fear conditioning, a very recent report indicates that cafeteria diet-fed rats froze less to the conditioning context but displayed enhanced freezing to the cue compared with chow-fed rats (Reichelt et al., 2015). Altogether, these results suggest that juvenile HFD consumption has a bidirectional effect on learning and memory processes, enhancing amygdala-dependent, cue-based memory while impairing hippocampal-dependent contextual memory.
Our study also brings out new findings on the effects of HFD on emotional memory. Albeit affecting long-term aversive memory, juvenile exposure to HFD has no effect on short-term memory. This rules out an effect of jHFD on CS and US perception (also supported by the normal postshock freezing) and suggests a specific effect on memory consolidation. Memory consolidation requires synthesis of new proteins (Davis and Squire, 1984; Dudai, 2004), and inhibiting protein synthesis in the BLA specifically impairs long-term memory of COA and auditory fear conditioning without affecting short-term memory (Schafe et al., 2000; Desgranges et al., 2008). Similarly, persistent forms of synaptic plasticity, such as the late phase of LTP, critically depend on the synthesis of new proteins (Lynch et al., 2007; Abraham and Williams, 2008). Interestingly, only jHFD-fed rats display the late phase of LTP in the BLA 1 h after high-frequency stimulation (Fig. 4D). In parallel, we show in the BLA, but not in the CeA, of these animals a higher protein expression of the immediate-early genes c-Fos and Egr-1 after gastric malaise. This corroborates a recent report indicating that chronic high-fat feeding in mice increases plasticity-related (BDNF and phospho-CREB) protein levels in the amygdala (Sharma et al., 2013) and suggests that juvenile exposure to HFD enhances protein synthesis after BLA stimulation, leading to long-term synaptic and behavioral changes.
To determine how HFD exposure during adolescence leads to enhanced consolidation of emotional memories, we investigated the role of glucocorticoids, since previous research has shown that GR activation in the BLA modulates consolidation of emotional memory as well as LTP in lean animals (Roozendaal and McGaugh, 1997; Miranda et al., 2008; Sarabdjitsingh et al., 2012). Moreover, adolescence is a decisive period for maturation of the HPA axis (Spear, 2000; McCormick and Mathews, 2010; Foilb et al., 2011), and previous reports indicate that chronic HFD exposure can alter HPA axis activity (Tannenbaum et al., 1998; Legendre and Harris, 2006; Sharma and Fulton, 2013). Finally, expression of Egr-1 (our results), BDNF, and phospho-CREB (Sharma et al., 2013), which are enhanced in the amygdala after HFD exposure, are molecular targets of activated GR (Revest et al., 2005, 2014; Chen et al., 2012). We found that jHFD induces a protracted LiCl-induced corticosterone release that correlates with BLA activation. Interestingly, such changes are not present when HFD exposure occurs at adulthood. Finally, blocking GR activation in the BLA attenuates the stronger aversive memory of jHFD-fed rats but has no effect in aHFD-fed rats, and systemic GR blockade restores normal synaptic plasticity in the BLA of jHFD-fed rats. These findings indicate that prolonged corticosterone release mediates, at least in part, the enhancement of both long-term aversive memory and amygdala synaptic plasticity through a longer-lasting GR activation.
In our previous studies, we demonstrated an increased susceptibility of the juvenile period to the effect of HFD on hippocampal-dependent plasticity and memory (Boitard et al., 2012, 2014; Valladolid-Acebes et al., 2013). Here, we generalize this notion to another memory system. However, there are two noticeable differences between the effects of jHFD on hippocampal and amygdala memory systems. First, we recently demonstrated that 1.5–2 months of juvenile HFD exposure was sufficient to affect hippocampal function (Boitard et al., 2012, 2014), whereas we find here that 3 months of HFD exposure starting at weaning is necessary to affect amygdala function. The faster impact of HFD on hippocampus could be related to the increased permeability of the blood–brain barrier specifically observed in this brain area in obese animals (Kanoski et al., 2010; Davidson et al., 2012). According to the hippocampal regulation of the HPA axis (Ulrich-Lai and Herman, 2009) and the role played by glucocorticoids in HFD-induced amygdala changes, it remains to be determined whether the early hippocampal alterations participate in the change of amygdala function occurring afterward. Second, as stated previously, juvenile HFD exposure induced an impairment of hippocampal function but an enhancement of amygdala function. This bidirectional effect on hippocampal and amygdala functions was previously reported in other situations such as chronic stress (Sandi and Pinelo-Nava, 2007; Lupien et al., 2009), aging (Misanin et al., 2002; Lister and Barnes, 2009), models of Alzheimer's disease (España et al., 2010), or PTSD (Kaouane et al., 2012), which are all characterized by deregulation of the HPA axis activity (Sapolsky et al., 1986; Sandi and Pinelo-Nava, 2007; Kaouane et al., 2012). In particular, PTSD is characterized by enduring and maladaptive emotional memory (Elzinga and Bremner, 2002; Layton and Krikorian, 2002), and some authors suggest that individuals with PTSD show over-consolidation of emotional memory (Mahan and Ressler, 2012). Interestingly, in humans, obesity has been associated with a higher prevalence of PTSD (Pagoto et al., 2012; Johannessen and Berntsen, 2013), particularly in obese adolescents (Britz et al., 2000; Perkonigg et al., 2009). Based on our results suggesting that juvenile obesity enhances emotional memories and given the fact that childhood and adolescent trauma predisposes individuals to develop PTSD (for review, see Gerson and Rappaport, 2013), future experiments are needed to determine whether and how juvenile obesity could also predispose to develop PTSD.
Footnotes
This work was supported by a PhD grant from AXA Research Fund (C.B.), Grant “Emergence de Jeune Equipe INRA 2010-2012” (G.F.), and Grant LABEX BRAIN ANR-10-LABX-43 (C.B. and G.F.). We thank P. Trifilieff, S. Tronel, and C. Dawson for help with the final text and P. Birac and M. Cadet for technical assistance and for taking care of the animals.
The authors declare no competing financial interests.
- Correspondence should be addressed to Guillaume Ferreira, Nutrition and Integrative Neurobiology (NutriNeuro), INRA 1286, Université de Bordeaux, Bâtiment UFR Pharmacie, 146 rue Léo Saignat, 33076 Bordeaux, France. guillaume.ferreira{at}bordeaux.inra.fr